Simple Moving Averages
Before looking at the financial values or the trading statistics of Horizon Pharma plc (HZNP), we will start our analysis with the SMA or Simple Moving Average values.
The SMA or Simple Moving Averages are commonly available for 20 Day, 50 Day and 200 Day Simple Moving Averages. For our stock under consideration here, Horizon Pharma plc (HZNP) has distance from 20 Day SMA is -2.87% while its distance from 50 day SMA is -18.19%. HZNP’s distance from 200 Day SMA is -36.37%.
While looking at the SMA values of Horizon Pharma plc (HZNP), the 200 simple moving average (SMA) is considered a key indicator by traders and market analysts for determining the overall long-term trend. The 200 SMA is considered so critically important a trend indicator that the event of the 50-day SMA crossing to the downside of the 200-day SMA is referred to as a death cross, signaling a serious bear market in a stock, index or other investment.
Last Trading Day Performance
On the last trading day, Horizon Pharma plc (HZNP) gained 0.88% closing at the price of $10.29 while the previous close of HZNP was $10.2.
Horizon Pharma plc (HZNP) traded with the volume of 5.94 Million shares while its average 3 months volume is at 4270 shares.
Horizon Pharma plc (HZNP) has a market capitalization of 1.67 Billion while its Major Index membership is at 0.
Shares of Horizon Pharma plc (HZNP) touched the day high at $10.50 while its day Low was at $10.13. In contrast, HZNP’s 52 week high hovers at $23.44 with its current distance from 52 week high value is -56.11%. Horizon Pharma plc (HZNP) 52 week low value is at $9.45 and its current distance from 52 week low value is 8.89%.
Volatility of the shares is also to be considered while making the investment decisions. As volatility place a very vital role in identifying the risk involved in the particular case. In our current pick, Horizon Pharma plc (HZNP) has weekly volatility of 3.95%% while its monthly volatility value is at 4.53%%.
Another indicator of risk for a particular security is “Beta”. A beta approximates the overall volatility of a security’s returns against the returns of a relevant benchmark (usually the S&P 500 is used). Currently Horizon Pharma plc (HZNP) has beta value of 1.4. This Beta value of Horizon Pharma plc (HZNP) shows that it has historically moved 140% for every 100% move in the benchmark.
For making investment decisions, Financial Ratios play a vital role. There is a large variety of Financial Ratios that can be considered while making an investment decision but here in the case of Horizon Pharma plc (HZNP), we will discuss a few.
Annual Dividend Yield of Horizon Pharma plc (HZNP) stands at 0%.
Price to Earning P/E ratio and Forward P/E stand at 0 and 8.58 respectively.
Horizon Pharma plc’s Quick Ratio shows the value of 1.5.
Debt to Equity ratio stands at 1.57 while Long Term Debt To Equity Ratio flashes the value of 1.56.